Brief: Australian Clinical Labs Says Mark Haberlin Appointed Interim Chair Of ACL Board
16/04/2025 09:26
April 16 (Reuters) - Australian Clinical Labs Ltd ACL.AX: MARK HABERLIN APPOINTED INTERIM CHAIR OF ACL BOARD MICHAEL ALSCHER TO RETIRE AS CHAIR Further company coverage: ACL.AX ((Reuters.Briefs@thomsonreuters.com))
Recent news on Australian Clinical Labs
See all newsBrief: Australian Clinical Labs Appoints Deloitte As Auditor
Australia's Optiscan rises after imaging more than 80 cases in ACL study
Australian Clinical Labs falls to over two-week low on trading ex-dividend
Australian Clinical Labs at 6-month high on upbeat full-year results, guidance
Brief: Australian Clinical Labs Says It Expects FY27 Revenue Of A$745-765 Million